Early chronic kidney disease in relation to body mass index in high risk outpatients

Ramajana Temimović, Senija Rašić, Damir Rebić, Alen Džubur, Belma Paralija

Abstract


The renal damage is an emerging complication of excess weight.  Aim of this study was to determine the occurrence of chronic kidney disease (CKD) in subjects depending on their weight and the influence of body mass index (BMI) on glomerular filtration (GF) rate decline in outpatients with hypertension and/or diabetes mellitus type 2.

Methods: This observational, cross sectional, pilot study included 200 adult patients suffering from hypertension and/or diabetes mellitus type 2 from March 2012. to March 2013. in the Institute for Occupational Medicine of Canton Sarajevo. Renal function was evaluated by using MDRD equation and measurement of microalbuminuria and proteinuria in 24-hour urine, using nefelometric method at the Institute of Clinical Biochemistry of the University Clinical Center in Sarajevo K/DOQI classification  was used to define the stages of CKD.

Results: Of the total 200 patients (62.5% male; mean age of 52.46 ± 8.2 years) most of them had a BMI of 25-30 (n=99; 49.5%). Most patients with a body mass index above 30 suffered from hypertension associated with diabetes mellitus type 2 (n=23; 34.3%,  p<0.05). The average values of BMI were statistically higher in men than in women (29.16±4.4 vs. 27.76±3.7). Early CKD was found in 118 patients (59.0%), mostly those with a BMI above 30 (63.8%).

Conclusion: Early detection of CKD in primary care should definitely be a priority, especially in high-risk patients. It is also necessary to increase work on the prevention of obesity in order to prevent disease progression.          


Full Text:

PDF

References


References

Kidney Disease Improving Global Outcomes (KDIGO). Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1-150.

Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-81.

Krikken AJ, Bakker JLS, Navis GJ. Role of renal haemodynamics in the renal risks of overweight. Nephrol Dial Transplant 2009; 24 (6): 1708-1711.

Thoenes M, Reil JC, Khan BV, Bramlage P,Volpe M, Kirch W, Böhm M. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag 2009; 5: 577-585.

Lawrence PMcM. Detection and progression of chronic kidney disease: does the rear-view mirror help? Nephrol Dial Transplant 2013; 28: 1076-1079.

Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens 2010; 19: 227-234.

Bakker SJL, Gansevoort RT, de Zeeuw D. Metabolic syndrome: a fata morgana? Nephrol Dial Transplant 2007; 22: 15-20.

Chen LI, Guh JY, Wu KD, Chen YM, Kuo MC, Chen TH, Chen HC. Modification of Diet in Renal Disease (MDRD) Study and CKD Epidemiology Collaboration (CKD-EPI) Equations for Taiwanese Adults. PLoS ONE. 2014; 9(6): e99645.doi:10.1371/journal.pone.0099645.

Grossfeld G, Wolf J J, Litwan M, Hricak H, Shuler C, Agerter D, Carroll P. Asymptomatic microscopic hematuria in adults: Summary of the AUA best practice policy recommendations. American Family Physician 2001; 63 (6): 1145–1154.

Fraser SDS, Roderick PJ, McIntyre NJ, Harris S, McIntyre C,Fluck R, Taal MW. Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria. PLoS One 2014; 9(5): 98261.

Blaslov K, Bulum T, Duvnjak L. Waist-to-height ratio is independently associated with chronic kidney disease in overweight type 2 diabetic patients. Endocr Res 2014; 23:1-5.

NKF KDOQI guidelines. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. AJKD 49 (2) Suppl 2; 2007.


Refbacks

  • There are currently no refbacks.